These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7295485)

  • 1. Long-term cyclophosphamide treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR and clinical response.
    Grimaldi MG
    Br J Clin Pharmacol; 1981 Oct; 12(4):503-6. PubMed ID: 7295485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term low dose ticlopidine treatment in rheumatoid arthritis: effects on serum sulphydryl levels, technetium index, erythrocyte sedimentation rate, and clinical disease activity.
    Grimaldi MG
    Eur J Clin Pharmacol; 1985; 29(2):165-8. PubMed ID: 3000794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sulfhydryl levels in rheumatoid patients treated with cyclophosphamide.
    Grimaldi MG
    Scand J Rheumatol; 1980; 9(4):237-40. PubMed ID: 7455636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term low dose haloperidol treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR, and clinical response.
    Grimaldi MG
    Br J Clin Pharmacol; 1981 Oct; 12(4):579-81. PubMed ID: 7295491
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum sulfhydryl levels in rheumatoid patients treated with haloperidol.
    Grimaldi MG
    Scand J Rheumatol; 1980; 9(4):225-8. PubMed ID: 7455635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sulphydryl levels in rheumatoid patients treated with alclofenac.
    Evans PH
    Curr Med Res Opin; 1975; 3(5):268-75. PubMed ID: 241596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of cyclophosphamide in rheumatoid arthritis.
    Townes AS; Sowa JM; Shulman LE
    Arthritis Rheum; 1976; 19(3):563-73. PubMed ID: 779796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic effects of cyclophosphamide treatment in rheumatoid arthritis.
    Alepa FP; Zvaifler NJ; Sliwinski AJ
    Arthritis Rheum; 1970; 13(6):754-60. PubMed ID: 5495387
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concentration of serum sulphydryl groups in patients with rheumatoid arthritis dependent on age and duration of disease].
    Janiszewski M; Gaweda J; Drzewoski J
    Wiad Lek; 1994 Sep; 47(17-18):654-8. PubMed ID: 7571613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sulphydryl concentrations and antirheumatic drugs in rheumatoid patients.
    Grimaldi MG
    J Pharm Pharmacol; 1980 Dec; 32(12):876. PubMed ID: 6110764
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide therapy for rheumatoid arthritis.
    Smyth CJ; Bartholomew BA; Mills DM; Steigerwald JC; Strong SJ; Recart S
    Arch Intern Med; 1975 Jun; 135(6):789-93. PubMed ID: 1093503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclophosphamide in rheumatoid polyarthritis. Clinical study. 45 cases. Seven year follow-up].
    Chaouat Y; Kanovitch B; Paquet J; Pélisson J; Rascovscki S; Faures B
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):751-8. PubMed ID: 5152706
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study.
    Csuka M; Carrera GF; McCarty DJ
    JAMA; 1986 May; 255(17):2315-9. PubMed ID: 3959321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis.
    Banford JC; Brown DH; Hazelton RA; McNeil CJ; Sturrock RD; Smith WE
    Ann Rheum Dis; 1982 Oct; 41(5):458-62. PubMed ID: 7125714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of cyclophosphamide in rheumatoid arthritis.
    Cooperating Clinics Committee of the American Rheumatism Association
    N Engl J Med; 1970 Oct; 283(17):883-9. PubMed ID: 4917724
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum antioxidant activity and related variables in rheumatoid arthritis. Behaviour during sulphydrylant treatment.
    Ambanelli U; Spisni A; Ferraccioli GF
    Scand J Rheumatol; 1982; 11(4):203-7. PubMed ID: 7178856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.
    Currey HL; Harris J; Mason RM; Woodland J; Beveridge T; Roberts CJ; Vere DW; Dixon AS; Davies J; Owen-Smith B
    Br Med J; 1974 Sep; 3(5934):763-6. PubMed ID: 4606370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are inflammation parameters true signs of activity? A contribution to the problem of process activity and progression in chronic polyarthritis].
    Chlud K
    Z Rheumatol; 1985; 44(1):14-9. PubMed ID: 2580400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.
    Amos RS; Constable TJ; Crockson RA; Crockson AP; McConkey B
    Br Med J; 1977 Jan; 1(6055):195-7. PubMed ID: 832072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
    Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.